about
Actions of a histone deacetylase inhibitor NSC3852 (5-nitroso-8-quinolinol) link reactive oxygen species to cell differentiation and apoptosis in MCF-7 human mammary tumor cellsEthanol-mediated CYP1A1/2 induction in rat skeletal muscle tissueGlutathione conjugation of busulfan produces a hydroxyl radical-trapping dehydroalanine metaboliteC8-arylguanine and C8-aruladenine formation in calf thymus DNA from arenediazonium ionsCobalt-mediated generation of reactive oxygen species and its possible mechanismReaction of Cr(VI) with ascorbate and hydrogen peroxide generates hydroxyl radicals and causes DNA damage: role of a Cr(IV)-mediated Fenton-like reactionA Polymorphic Variant of AFAP-110 Enhances cSrc ActivityCYP2C9 genotype-dependent effects on in vitro drug-drug interactions: switching of benzbromarone effect from inhibition to activation in the CYP2C9.3 variant.Src binds cortactin through an SH2 domain cystine-mediated linkage.Nanoscale electron transport measurements of immobilized cytochrome P450 proteins.Generation of thiyl and ascorbyl radicals in the reaction of peroxynitrite with thiols and ascorbate at physiological pH.Immobilized Cytochrome P450 for Monitoring of P450-P450 Interactions and MetabolismPreparation, characterization, and substrate metabolism of gold-immobilized cytochrome P450 2C9The use of 2-hydroperoxytetrahydrofuran as a reagent to sequence cytosine and to probe non-Watson-Crick DNA structures.Epoxidation of the methamphetamine pyrolysis product, trans-phenylpropene, to trans-phenylpropylene oxide by CYP enzymes and stereoselective glutathione adduct formation.DNA alkylation and mutagenicity of related hydroxypropylating and methylating agents in V79 cells.The use of immobilized cytochrome P4502C9 in PMMA-based plug flow bioreactors for the production of drug metabolitesMeasurement of electron transfer through cytochrome P450 protein on nanopillars and the effect of bound substrates.Electrocatalytic drug metabolism by CYP2C9 bonded to a self-assembled monolayer-modified electrodeA general synthesis of C8-arylpurine phosphoramidites.Synthesis, properties, and NMR studies of a C8-phenylguanine modified oligonucleotide that preferentially adopts the Z DNA conformation.Tumor induction with hexanal methylformylhydrazone of Gyromitra esculenta.The conformational effect of para-substituted C8-arylguanine adducts on the B/Z-DNA equilibrium.A conformational NMR analysis of methymycin aglycones: complete and unambiguous assignments of stereochemically diverse glycosylated methymycin analogs by 1D and 2D NMR techniques and molecular modeling.Single C8-Arylguanine modifications render oligonucleotides in the Z-DNA conformation under physiological conditions.One-electron reduction of vanadate by ascorbate and related free radical generation at physiological pH.Base pairing of 8-oxoguanosine and 8-oxo-2'-deoxyguanosine with 2'-deoxyadenosine, 2'-deoxycytosine, 2'-deoxyguanosine, and thymidine.8-Arylguanine adducts from arenediazonium ions and DNA.The mutagenicity of capsaicin and dihydrocapsaicin in V79 cellsAgaricus bisporus: an assessment of its carcinogenic potencyHeteroactivator effects on the coupling and spin state equilibrium of CYP2C9C8-Guanine modifications: effect on Z-DNA formation and its role in cancerAppropriateness of Term Limits for Administrative Appointments in Pharmacy Programs
P50
Q23909995-693D542B-D4BF-4C66-B2BD-5955D5FA7540Q23911056-87FBD477-6B03-4FD6-9BEA-E7621CF783C7Q23911250-43579DE1-1450-4536-B9B2-750D7B193E5BQ23919454-258F7409-425F-4232-BE16-861F5C6FF24DQ23921732-02E9D78F-B2C8-4017-BA5F-D6C2460E7B77Q28240295-2507DCC8-72A5-4B75-ADCD-3C25F51FA406Q28397489-0C804C25-31DC-4F48-88A5-8E2EFEDD9DEFQ34426453-6A07D8A7-3D17-44C2-8023-EBAA46A42E85Q36648258-3931CB03-B5A0-4926-9CBA-59AC71DC22F8Q36687303-6520D0D1-AC4F-43BF-B86F-8C4DEF8B3C0EQ36709759-21D06936-E068-425F-879E-BB238FCEE253Q36852513-937F07D7-536A-4DA1-9AA8-EE1C8A81E98FQ36916893-B4ECB149-66F6-4897-885E-5B0E61B408B4Q40393173-E66EF996-A5A5-49C7-8A3D-4B9AE895F278Q40394330-8A6B8A01-DC81-4276-8A8A-942610778FE5Q41587026-9F06DE25-3A90-472D-9CF6-4A84014412D3Q41816904-981859EB-53C0-4C3F-95BC-E5E7118438FDQ41892868-C519AADB-EB1D-40F4-BD99-660CA55AE53DQ42087643-57BF74A2-BB79-440B-ACA7-6FD791650C74Q43270560-5270CA35-1ABF-4F7F-B6E0-C091E660278FQ44622753-257F3249-5B7A-4BE9-A201-2D4B20CB8C62Q44837559-693EACF7-63AA-4827-8AD7-EBDBC73DF183Q44962643-CB6390D2-E861-4E87-B77A-67F479EED701Q44982675-A68149C0-B1B5-4988-AECA-44F0CA17757DQ44999231-4A4A30A7-60DD-4464-B41C-529B27694720Q45087808-2C7ECC2B-31DC-449E-B39A-A2C68D2263DEQ45091382-EE251F40-661D-460D-B968-6E7A96DA70BEQ45098621-38346455-B967-4951-91AB-D39CEB1BC840Q69554349-0B48BF07-DA84-447D-B8B4-7CD0936E1AA9Q72006159-9E3E143E-F2CA-4249-9DCC-3BB9294292CEQ82871572-9C656544-D0B0-4C71-ABD4-0A87A2823EC0Q88037246-A2726D79-5680-4B13-AEEC-3A6B3FCC9109Q91940819-B784ACEB-1F47-4D5C-97C8-CA6DDB746C1F
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Peter M Gannett
@ast
Peter M Gannett
@en
Peter M Gannett
@es
Peter M Gannett
@nl
type
label
Peter M Gannett
@ast
Peter M Gannett
@en
Peter M Gannett
@es
Peter M Gannett
@nl
prefLabel
Peter M Gannett
@ast
Peter M Gannett
@en
Peter M Gannett
@es
Peter M Gannett
@nl
P108
P106
P108
P31
P496
0000-0002-7859-5468